Eye Health News and Research

Latest Eye Health News and Research

Ocular tuberculosis presents a diagnostic challenge

Mycobacterial ocular inflammation typically arises without concomitant systemic or pulmonary disease and should be suspected in patients who do not respond to anti-inflammatory therapy.

29 Apr 2013

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that ILUVIEN®, the first sustained release pharmaceutical product for the treatment of chronic diabetic macular edema, is now available in the United Kingdom.

29 Apr 2013

Md. insurer proposes 25% rate hike because of health reform

The state's largest insurer -- CareFirst BlueCross BlueShield -- wants to raise rates for individuals buying coverage on their own in order to offset the cost of the health law requiring that insurers accept patients with pre-existing conditions.

26 Apr 2013

High-energy proton beam therapy offers potential treatment option for eye cancer

Particle beams - from low energy beams with exotic ions through to extremely high energy light sources - are revolutionising the way we view the world and creating potential for new industries, but the instrumentation for controlling the beams is still in its infancy.

26 Apr 2013

Scientists develop new technique for imaging nanoparticle dynamics with atomic resolution

The macroscopic effects of certain nanoparticles on human health have long been clear to the naked eye. What scientists have lacked is the ability to see the detailed movements of individual particles that give rise to those effects.

26 Apr 2013

Fixed-dose combination of drugs effectively lowers IOP

A fixed-dose combination of brinzolamide and brimonidine is more effective than either drug given alone for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, results of a phase III trial indicate.

25 Apr 2013

Omeros presents clinical data of OMS302 on reducing pupil constriction during ILR at ASCRS meeting

Omeros Corporation today reported analyses of Phase 2 and Phase 3 clinical data showing the favorable impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement.

25 Apr 2013

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for sight threatening eye diseases, today announced that a phase 2b/3 clinical trial investigating emixustat hydrochloride in subjects with geographic atrophy associated with dry age-related macular degeneration has been initiated.

25 Apr 2013

Retinoblastoma more invasive at diagnosis in racial, ethnic minority children

When the eye cancer retinoblastoma is diagnosed in racial and ethnic minority children whose families don't have private health insurance, it often takes a more invasive, potentially life-threatening course than in other children, probably because of delays in diagnosis, Dana-Farber/Children's Hospital Cancer Center researchers will report at the 26th annual meeting of the American Society of Pediatric Hematology Oncology being held in Miami, April 24-27.

25 Apr 2013

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn’t. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

24 Apr 2013

Study reveals 3-D motion detection system could help prevent shoulder injuries in baseball pitchers

A new 3-D motion detection system could help identify baseball pitchers who are at risk for shoulder injuries, according to a new study.

24 Apr 2013

New visual search rehabilitation game for visually impaired children

Visually impaired children could benefit from a revolutionary new computer game being developed by a team of neuroscientists and game designers.

24 Apr 2013

BD receives FDA approval for second prefilled injectable drug

BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD, announced today that the U.S. Food and Drug Administration has approved the second drug to be offered in the recently launched BD Simplist line of ready-to-administer prefilled generic injectables.

From BD (Becton, Dickinson and Company) 24 Apr 2013

PPMI to launch additional study to evaluate multiple potential biomarkers for Parkinson's disease

The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.

24 Apr 2013

Home-based health education about diseases most effective, finds study

In the first study of its kind, lay health workers increased screening rates for hepatitis B virus (HBV) and knowledge about the disease among a group of Asian Americans, known as the Hmong, UC Davis researchers have found.

24 Apr 2013

Researchers explore new technique to determine the activity of different calcium channels in cancer cells

Two Wayne State University researchers are working on a technique that could lead to easier, faster identification of cancer tumors that can be effectively treated by calcium channel-based therapies.

23 Apr 2013

Researchers urge doctors to consider Lyme disease as cause when presented with skin lesions

When a person contracts Lyme disease, quick diagnosis and treatment are essential to avoiding long term complications. But the diagnostic process may be delayed if a physician does not recognize a skin rash caused by Lyme disease because it does not have the bull's-eye appearance that is best known to physicians and the public.

23 Apr 2013

DNAzymes, gold nanoparticles and disease detection: an interview with Dr Chan and Kyryl Zagorovsky, University of Toronto

Gold nanoparticles are tiny spherical particles made out of gold atoms with sizes on nanometre scale. This is around 1,000 times smaller than the thickness of human hair.

23 Apr 2013

Researchers find innovative approach to treat lazy eye disorder

A research team led by Dr. Robert Hess from McGill University and the Research Institute of the McGill University Health Centre has used the popular puzzle video game Tetris in an innovative approach to treat adult amblyopia, commonly known as "lazy eye".

23 Apr 2013

Cerecor obtains exclusive, worldwide rights to NR2B receptor antagonist from Merck

Cerecor Inc, a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today announced that it has acquired exclusive, worldwide rights from Merck, known as MSD outside the United States and Canada, to develop and commercialize MK-0657, a small molecule NMDA receptor subunit 2B (NR2B) antagonist for all human indications, including depression.

22 Apr 2013

Eye Health News and Research

Latest Eye Health News and Research

Ocular tuberculosis presents a diagnostic challenge

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

Md. insurer proposes 25% rate hike because of health reform

High-energy proton beam therapy offers potential treatment option for eye cancer

Scientists develop new technique for imaging nanoparticle dynamics with atomic resolution

Fixed-dose combination of drugs effectively lowers IOP

Omeros presents clinical data of OMS302 on reducing pupil constriction during ILR at ASCRS meeting

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Retinoblastoma more invasive at diagnosis in racial, ethnic minority children

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Study reveals 3-D motion detection system could help prevent shoulder injuries in baseball pitchers

New visual search rehabilitation game for visually impaired children

BD receives FDA approval for second prefilled injectable drug

PPMI to launch additional study to evaluate multiple potential biomarkers for Parkinson's disease

Home-based health education about diseases most effective, finds study

Researchers explore new technique to determine the activity of different calcium channels in cancer cells

Researchers urge doctors to consider Lyme disease as cause when presented with skin lesions

DNAzymes, gold nanoparticles and disease detection: an interview with Dr Chan and Kyryl Zagorovsky, University of Toronto

Researchers find innovative approach to treat lazy eye disorder

Cerecor obtains exclusive, worldwide rights to NR2B receptor antagonist from Merck

Genetics & Genomics - Second Edition eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Newsletters you may be interested in